Delivery Order SPE2DB20D1100-SPE2DB24FB2U0
- Not listed
- The U.S. government awarded a Delivery Order contract worth $1,669.95 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, with a period of performance through May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a delivery order valued at $1,443.79. The contract has a period of performance through March 12, 2024 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The U.S. government awarded a Delivery Order contract valued at $156,131.50 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has a completion date of June 18, 2024, is for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA through December 2025...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $1,260.58 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract was awarded without a set-aside designation and has an ultimate completion date of June 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, will provide a variety of pharmaceutical products and medical supplies to support the DLA's mission of providing logistics, acquisition, and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,521.95. The contract is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025, serving as...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, worth $1,623.54, is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of medical commodities to DLA facilities...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a Firm Fixed Price Delivery Order contract valued at $1,598.40 to Amerisourcebergen Drug Corp's Corporate Office Division. This contract, which has a completion date of June 27, 2024, is for the provision of pharmaceutical products and medical supplies to the DLA. Amerisourcebergen, a major pharmaceutical distribution company, also holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of a diverse range of medical and pharmaceutical products. The contract is a Delivery Order with a Firm Fixed Price, valued at $2,343.24, and has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- The U.S. government awarded a Delivery Order contract worth $1,377.33 to Amerisourcebergen Drug Corp's Corporate Office Division. This contract, with an ultimate completion date of May 22, 2024, is for the provision of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,392.44. The contract is for pharmaceutical and medical supply products to support the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to provide a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB2U0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,323.00 for the supply of pharmaceutical product 4564286297 (ALBURX (HUMAN) 5% VIAL 500ML) to the Defense Logistics Agency (DLA). The contract has a completion date of May 6, 2024 and was awarded on a firm fixed price basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/15/24 |